Replay: Weekend Watch | Are we Past Peak? Health Care Policy in the Next Term

10/30/20 03:28PM EDT

Replay: Weekend Watch | Are we Past Peak? Health Care Policy in the Next Term - 20201027 Election Preview

You will always learn someting new when Hedgeye's leading political junkies, JT Taylor, Chief Political Strategist and Daryl Jones, Director of Research get together. This week, they were nice enough to spend time with me on health policy and what the implications are for a Biden or Trump victory next week. Take a break from earnings and start thinking about health care in the next term (and keep your eye on Medicare Advantage!).

CLICK HERE for event details (includes video/audio and materials link)

Timestamps:

0-1:21 Introduction

1:21 - 5:45 SCOTUS Confirmation Hearings: Is Health Care Past Peak as an Issue?

5:45 - 11:29 Update on the Race w/JT

11:30 - 14:20 Daryl's Perspective on the Race & Betting Markets

14:21 - 18:00 The Changing Nature of Electorate and Money as the Mother's Milk of Politics

18:01 - 19:43 Implications of Left Flank's Influence in Election and a Biden Administration

19:43 - 26:43 Biden's Centrist Health Policy and Left-leaning in House v Moderate Senate

26:43 - 29:14 Trump Health Policy Post-election and His "Plan"

29:14 - 33:57 Other Health Policies Including Drug Prices and Surprise Billing as Release Valve for Left's Agitation

33:57 - 35:38 Most Favored Nation Rule as Leverage and Set-up for Negotiations with Pharma

35:39 - 40:11 Return of Budget Hawks and Pressure on Medicare

40:11 - 42:19 - Future of Medicare Advantage in a Left-leaning world

42:19 - 46:57 FDA's Regulation of CBD and Future of Senate Support if Sen. Corey Gardner's Departure

46:58 - 53:48 Q & A

Call with questions.

Emily Evans
Managing Director – Health Policy



Twitter
LinkedIn

Emily Evans
Managing Director – Health Policy



Twitter
LinkedIn

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.